Compare Johnson & Johnson (JNJ) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Okta, Inc. — how do they compare? Johnson & Johnson trades at $250.89 (market cap $598.96B), while Okta, Inc. trades at $141.26 (market cap $25.79B). The key difference: Johnson & Johnson is far larger — about 23.2× Okta, Inc.'s market cap, and Johnson & Johnson pays a 2.15% dividend while Okta, Inc. pays none. Which is the better fit depends on your goals.
| JNJ | OKTA | |
|---|---|---|
Market Cap | $598.96B | $25.79B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $154.62 |
52-Week Low | $164.36 | $62.93 |
Enterprise Value | $631.90B | $23.62B |
Dividend Yield | 2.15% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
